Ocular Therapeutix Inc. (OCUL)
5.89
-1.25 (-17.51%)
At close: Mar 03, 2025, 3:59 PM
5.93
0.59%
After-hours: Mar 03, 2025, 04:16 PM EST
Ocular Therapeutix Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -80.74M | -71.04M | -6.55M | -155.64M | -86.37M | -59.98M | -63.39M | -44.7M | -39.75M | -28.65M | -13.32M | -14.09M |
| Depreciation & Amortization | 2.98M | 2.11M | 2.42M | 2.77M | 2.53M | 2.29M | 1.63M | 881K | 754K | 547K | 404K | 404K |
| Stock-Based Compensation | 17.82M | 16.96M | 14.98M | 7.53M | 8.76M | 7.48M | 7.32M | 5.96M | 4.64M | 2.64M | 476K | 243K |
| Other Working Capital | -2.81M | 2.88M | 4.24M | 11.58M | 1.08M | 1.45M | 2.6M | 2.27M | 20K | 1.85M | 250K | 8K |
| Other Non-Cash Items | -2.9M | -8.99M | 4.63M | 4.41M | 3.68M | 397K | 408K | 371K | 166K | 2.47M | 46K | 86K |
| Deferred Income Tax | n/a | n/a | -78.12M | 86.19M | -4.3M | n/a | 9K | 1.42M | -58K | 332K | -14K | 49K |
| Change in Working Capital | -7.41M | 1.35M | -2.9M | 1.18M | -1.88M | 585K | 3.55M | 2.08M | 503K | 2.16M | -240K | 726K |
| Operating Cash Flow | -70.23M | -59.6M | -65.55M | -53.55M | -77.58M | -49.23M | -50.47M | -34M | -33.74M | -20.5M | -12.64M | -12.59M |
| Capital Expenditures | -6.09M | -3.71M | -1.19M | -841K | -2.24M | -1.89M | -8.25M | -1.92M | -1.78M | -1.26M | -387K | -203K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 2K | 7K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -3M | -41.7M | -91.68M | -37.33M | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 38.2M | 80.68M | 54.83M | n/a | n/a | 4.02M |
| Other Investing Acitivies | n/a | -3.71M | n/a | n/a | n/a | n/a | 114K | -1.5M | 60K | -37.33M | n/a | 4.02M |
| Investing Cash Flow | -6.09M | -3.71M | -1.19M | -841K | -2.24M | -1.89M | 27.07M | 35.57M | -38.57M | -38.59M | -387K | 3.81M |
| Debt Repayment | 56.35M | n/a | -445K | n/a | 37.27M | 6.38M | 2.4M | n/a | 397K | 12.6M | -1.82M | 3.51M |
| Common Stock Repurchased | n/a | n/a | 985K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.38M | 1.45M | 3.3M | 3.33M | 529K | 694K | 370K | -42K | -306K | -3.15M | 8.5M | 23.79M |
| Financial Cash Flow | 169.83M | 1.45M | 2.85M | 228.01M | 75.34M | 68.64M | 32.01M | 585K | 65.7M | 78.97M | 6.68M | 27.3M |
| Net Cash Flow | 93.51M | -61.86M | -63.89M | 173.62M | -4.47M | 17.52M | 8.6M | 2.15M | -6.61M | 19.89M | -6.35M | 18.52M |
| Free Cash Flow | -76.32M | -63.32M | -66.74M | -54.4M | -79.82M | -51.12M | -58.73M | -35.92M | -35.52M | -21.76M | -13.03M | -12.79M |